STAT

He calls animal testing ‘taxpayer-funded torture.’ He got the FDA to listen

Anthony Bellotti played a key role in pressuring the FDA to shut down a nicotine-addiction study in which four monkeys died and launch an investigation of its animal research program.

In 1995, when Anthony Bellotti was 17 and slogging through a summer internship in an animal research lab, he was struck not by how the work could help the millions of people suffering from heart disease, but by the plight of the pigs being hoisted by their hind legs onto tables.

“They were always screaming,” he said. “I thought, ‘Something’s wrong with this picture.’”

He still hoped to one day join his father in the medical field, but the experience triggered a more lasting ambition: rolling back animal testing, which helped refine vaccines that saved millions from polio and smallpox, among others, as well as treatments for many other diseases.

Now the 39-year-old founder of an animal rights group, Bellotti last month achieved an important victory for opponents of animal testing. He played a key role

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanofi Licensing Novavax’s Covid Shot, Moderna’s RSV Vaccine, And More
Sanofi said it has reached a licensing deal to sell Novavax’s Covid shot as well as to try to combine the vaccine with Sanofi’s own flu vaccine.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks